Effect of treatment of the infected pregnant woman and her foetus
- 1 January 2000
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pyrimethamine-sulfadoxine Treatment of Congenital Toxoplasmosis: Follow-up of 78 Cases Between 1980 and 1997Scandinavian Journal of Infectious Diseases, 1998
- Vertical transmission of toxoplasma by human immunodeficiency virus–infected womenAmerican Journal of Obstetrics and Gynecology, 1997
- LOW RISK OF CONGENITAL TOXOPLASMOSIS IN CHILDREN BORN TO WOMEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUSThe Pediatric Infectious Disease Journal, 1997
- Classification system and case definitions ofToxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspringEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Termination of pregnancy for maternal toxoplasmosisThe Lancet, 1994
- Toxoplasmosis in PregnancyClinical Infectious Diseases, 1994
- In utero Treatment of Toxoplasmic Fetopathy with the Combination Pyrimethamine-SulfadiazineFetal Diagnosis and Therapy, 1993
- Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1The Pediatric Infectious Disease Journal, 1990
- Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatmentThe Journal of Pediatrics, 1989
- Prenatal Management of 746 Pregnancies at Risk for Congenital ToxoplasmosisNew England Journal of Medicine, 1988